首页 > 市场调查报告书 > 医疗设备

过敏诊断和治疗市场规模、份额和成长分析（按类型、过敏原类型、检测类型和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1895891

过敏诊断和治疗市场规模、份额和成长分析（按类型、过敏原类型、检测类型和地区划分）—产业预测，2026-2033年

Allergy Diagnostics and Therapeutics Market Size, Share, and Growth Analysis, By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled), By Test Type, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，过敏诊断和治疗市场规模将达到 333.9 亿美元，到 2025 年将成长至 363.3 亿美元，到 2033 年将成长至 713.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.8%。

受多种因素影响，全球过敏诊断和治疗市场预计将呈现强劲成长。日益严重的环境污染和医疗保健服务的可近性提高是关键驱动因素。过敏性疾病的增加带来了巨大的经济压力，促使各机构增加对过敏诊断的投资。不健康的饮食习惯和日益严重的污染等生活方式改变也进一步推动了市场需求。食物过敏的显着增加（主要由于缺乏饮食意识）预计将推动对诊断解决方案的需求。此外，行动医疗技术的融合以及对先进治疗策略的持续研究也促进了市场扩张。包括创新血液检测在内的技术进步为该领域的成长提供了巨大的机会。

过敏诊断与治疗市场驱动因素

与农村地区相比，都市区过敏性疾病的发生率显着更高，这主要是由于城市环境中环境污染物的暴露量更高。这一成长趋势凸显了开发有效过敏诊断和治疗方法的紧迫性。随着都市化的加快，对创新解决方案的需求预计将会增加，以应对和管理这些过敏症状，从而推动市场发展。此外，人们对过敏对生活品质影响的认识不断提高，也进一步推动了对更佳诊断工具和治疗方法的追求，进而促进了过敏诊断和治疗行业的成长。

过敏诊断和治疗市场的限制因素

过敏诊断和治疗市场面临许多挑战，这些挑战可能会阻碍其成长。其中一个关键因素是过敏诊断设备成本的不断上升。这种经济负担可能会阻碍医疗机构采用最新技术。此外，过敏专家的短缺可能会加剧这种情况，导致缺乏能够解读检测结果并有效管理患者照护的专业人员。这些障碍凸显了进行市场调查的必要性，该研究需要全面分析近期发展、法规、竞争格局以及新兴领域的机会。这些资讯对于希望了解市场复杂性并推动未来成长倡议的相关人员至关重要。

过敏诊断和治疗市场的发展趋势

受全球过敏性疾病盛行率不断上升的推动，过敏诊断和治疗市场正经历强劲成长。生活方式的改变、环境污染和饮食习惯的变化导致过敏症发病率上升，因此对创新诊断工具和有效治疗方法的需求日益增长。个人化医疗和免疫疗法等技术的进步也提升了过敏症的管理能力。此外，人们对过敏原及其健康影响的认识和教育的不断提高也推动了市场扩张，使该行业成为医疗保健领域的重要组成部分。

Thermo Fisher Scientific Inc.（US）
Siemens Healthineers（Germany）
Danaher（US）
Omega Diagnostics Group PLC（UK）
bioMerieux SA（France）
Romer Labs Division Holding（Austria）
EUROIMMUN Medizinische Labordiagnostika AG（Germany）
HollisterStier Allergy（US）
NEOGEN Corporation（US）
Eurofins Scientific（Luxembourg）
Minaris Medical America Inc.（US）
HOB Biotech Group Corp. Ltd.（China）
HYCOR Biomedical（US）
R-Biopharm AG（Germany）
AESKU.GROUP GmbH（Germany）
ACON Laboratories Inc.（US）
Lincoln Diagnostics Inc.（US）
Astra Biotech GmbH（Germany）
ERBA Group（UK）

结论与建议

简介目录

Product Code: SQMIG35H2183

Allergy Diagnostics and Therapeutics Market size was valued at USD 33.39 Billion in 2024 and is poised to grow from USD 36.33 Billion in 2025 to USD 71.33 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global allergy diagnostics and therapeutics market is poised for robust growth due to a myriad of influencing factors. Rising environmental pollution levels and enhanced healthcare insurance accessibility are key drivers. The increasing prevalence of allergic diseases is exerting significant economic pressure, prompting organizations to invest more in allergy diagnostics. Shifting lifestyle patterns, characterized by unhealthy dietary choices and heightened pollution, further accelerate market demand. A notable surge in food allergies, largely stemming from a lack of dietary awareness, is expected to escalate the need for diagnostic solutions. Additionally, the integration of mobile health technologies and ongoing research into advanced treatment strategies are catalyzing market expansion. Technological advancements, including innovative blood tests, present considerable opportunities for growth in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics and Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics and Therapeutics Market Segments Analysis

Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics and Therapeutics Market

The growing prevalence of allergic disorders is significantly higher in urban populations than in rural counterparts, largely attributed to the heightened exposure to environmental pollutants found in city settings. This rising trend underscores a pressing need for effective allergy diagnostics and therapeutics. As urbanization continues to expand, the demand for innovative solutions to address and manage these allergic conditions is likely to increase, driving advancements in the market. Additionally, the awareness surrounding the impact of allergies on quality of life further fuels the pursuit of improved diagnostic tools and treatment options, fostering growth within the Allergy Diagnostics and Therapeutics sector.

Restraints in the Allergy Diagnostics and Therapeutics Market

The Allergy Diagnostics and Therapeutics market faces significant challenges that could impede its growth, primarily due to the escalating costs associated with allergy diagnostic instruments. This financial burden may deter healthcare providers from adopting the latest technologies. Additionally, a lack of allergists may exacerbate the situation, creating a shortage of skilled professionals to interpret test results and manage patient care effectively. Such obstacles underscore the necessity for comprehensive market analysis encompassing recent developments, regulations, competitive landscape, and opportunities in emerging areas. This information is vital for stakeholders aiming to navigate the complexities of the market and drive future growth initiatives.

Market Trends of the Allergy Diagnostics and Therapeutics Market

The Allergy Diagnostics and Therapeutics market is experiencing robust growth, driven by the rising prevalence of allergic diseases globally. As lifestyle changes, environmental pollution, and shifts in dietary patterns contribute to the surge in allergies, there is an escalating demand for innovative diagnostic tools and effective treatment options. Advancements in technology, such as the development of personalized medicine and immunotherapy, are also enhancing the capabilities of allergy management. Additionally, increased awareness and education surrounding allergens and their impact on health further fuel the market's expansion, positioning it as a critical sector in the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Allergy Diagnostics and Therapeutics Market Size by Type & CAGR (2026-2033)

Market Overview
Diagnostics
- Instruments
- Consumables
- Services
Therapeutics
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anti-Cholinergic
- Immuno-Modulators
- Epinephrine
- Immunotherapy

Global Allergy Diagnostics and Therapeutics Market Size by Allergen Type & CAGR (2026-2033)

Market Overview
Food
- Dairy Products
- Poultry Product
- Tree Nuts
- Peanuts
- Shellfish
- Wheat
- Soys
- Other Food Allergens
Inhaled
Drug
Other Allergens

Global Allergy Diagnostics and Therapeutics Market Size by Test Type & CAGR (2026-2033)

Market Overview
In Vivo Test
- Skin Prick Test
- Intradermal Test
- Patch Test
In Vitro Test

Global Allergy Diagnostics and Therapeutics Market Size & CAGR (2026-2033)

North America (Type, Allergen Type, Test Type)
- US
- Canada
Europe (Type, Allergen Type, Test Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Allergen Type, Test Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Allergen Type, Test Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Allergen Type, Test Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Diagnostics Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Romer Labs Division Holding (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HollisterStier Allergy (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NEOGEN Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minaris Medical America Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOB Biotech Group Corp. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HYCOR Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R-Biopharm AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AESKU.GROUP GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lincoln Diagnostics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astra Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ERBA Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments